Evidence map›Paper›PMID 35725522›Full record

ArticleInfectious diseases of poverty2022

Defensins as a promising class of tick antimicrobial peptides: a scoping review.

Jiahui Wu, Xia Zhou, Qiaoqiao Chen, Zhiqiang Chen, Jinyu Zhang, Lele Yang, Yuxuan Sun, Guohui Wang, Jianfeng Dai, Tingting Feng

Open access · goldAbstract readScoping Review
In one paragraph

Article in Infectious diseases of poverty, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Comparative analysis of defensin expression inFrontiers in veterinary science · 2026
    Article
  6. Review
  7. Article
  8. Update on antimicrobial peptides: key elements inThe Journal of general virology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Cecropin anisaxin-2S hasFrontiers in immunology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jiahui Wu *Institute of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China.
Xia Zhou *School of Biology and Basic Medical Science, Suzhou Medical College of Soochow University, Suzhou, China.
Qiaoqiao Chen *Institute of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China.
Zhiqiang ChenDepartment of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jinyu ZhangInstitute of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China.
Lele YangInstitute of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China.
Yuxuan SunInstitute of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China.
Guohui WangSchool of Life Science and Technology, Weifang Medical University, Weifang, China. wanggh@wfmc.edu.cn.
Jianfeng DaiInstitute of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China. daijianfeng@suda.edu.cn.
Tingting FengInstitute of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China. ttfeng@suda.edu.cn.ORCID http://orcid.org/0000-0002-6282-1555
Soochow University · CNWeifang Medical University · CN

Funding

Jiangsu Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University 202010285133YNational Natural Science Foundation of China 32170142National Natural Science Foundation of China 81271792National Natural Science Foundation of China 81971917Natural Science Foundation of Jiangsu Province BK20211310Open Project Fund from State Key Laboratory of Genetic Engineering, , Fudan University SKLGE1903the 23rd Undergraduates Extracurricular Academic Research Fund, Soochow University KY20210120A
6 · The paper itself

Abstract

backgroundTicks are hematophagous parasites that transmit an extensive range of pathogens to their vertebrate hosts. Ticks can destroy invading microorganisms or alleviate infection via their rudimentary but orchestrated innate immune system. Antimicrobial peptides (AMPs) are important components of tick innate immunity. Among these humoral effector molecules, defensins are well-studied and widely identified in various species of Ixodidae (hard ticks) and Argasidae (soft ticks). This review was aimed at presenting the characterization of tick defensins from structure-based taxonomic status to antimicrobial function. MAIN TEXT: All published papers written in English from 2001 to May 2022 were searched through PubMed and Web of Science databases with the combination of relevant terms on tick defensins. Reports on identification and characterization of tick defensins were included. Of the 329 entries retrieved, 57 articles were finally eligible for our scoping review. Tick defensins mainly belong to the antibacterial ancient invertebrate-type defensins of the cis-defensins superfamily. They are generally small, cationic, and amphipathic, with six cysteine residues forming three intra-molecular disulfide bonds. Tick defensins primarily target membranes of a variety of pathogens, including Gram-positive and Gram-negative bacteria, fungi, viruses, and protozoa. Since tick defensins have a high degree of variability, we summarize their common biological properties and enumerate representative peptides. Along with the various and potent antimicrobial activities, the role of tick defensins in determining vector competence is discussed.

conclusionsDue to their broad-spectrum antimicrobial activities, tick defensins are considered novel candidates or targets for controlling infectious diseases.

Indexed as

Anti-Infective AgentsIxodidaeTicksAnimalsAnti-Bacterial AgentsAntimicrobial PeptidesDefensinsGram-Negative BacteriaGram-Positive BacteriaAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial PeptidesDefensinsAntimicrobial activityAntimicrobial peptideDefensinTick

Identifiers

PMID35725522
PMCPMC9208123
OpenAlexW4283165026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.